CIK 0001815974 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Anebulo Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ANEB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851170950
- Phone
- 737 203 5270
- Business address
- C/O ANEBULO PHARMACEUTICALS, INC., 1017 RANCH ROAD 620 SOUTH, SUITE 107, LAKEWAY, TX, 78734
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-13 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | Lin Kenneth Director | Grant or award · Stock Option (right to buy) | +2,482 | 2,482 | ||
| 2024-06-13 | Lawler Joseph F. Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | Lawler Joseph F. Director | Grant or award · Stock Option (right to buy) | +6,618 | 6,618 | ||
| 2024-06-13 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | Aryeh Jason Director | Grant or award · Stock Option (right to buy) | +2,482 | 2,482 | ||
| 2024-06-13 | SHAH BIMAL R. Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | SHAH BIMAL R. Director | Grant or award · Stock Option (right to buy) | +3,309 | 3,309 | ||
| 2024-06-13 | English Aron R. Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | English Aron R. Director | Grant or award · Stock Option (right to buy) | +1,324 | 1,324 | ||
| 2024-06-13 | Kupchyk Areta Director | Grant or award · Stock Option (right to buy) | +41,667 | 41,667 | ||
| 2024-06-13 | Kupchyk Areta Director | Grant or award · Stock Option (right to buy) | +1,324 | 1,324 | ||
| 2024-02-29 | Cundy Kenneth C Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +72,613 | 72,613 | ||
| 2024-02-29 | Cundy Kenneth C Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +72,613 | 72,613 | ||
| 2023-12-18 | English Aron R. Director | Gift | −300,000 | 0 | ||
| 2023-12-18 | English Aron R. Director | Gift | +300,000 | 5,366,290 | ||
| 2023-11-13 | English Aron R. Director | Grant or award | +300,000 | 300,000 | ||
| 2023-10-06 | Cunningham, Richard Anthony Chief Executive Officer | Grant or award · Stock Option (right to buy) | +600,000 | 600,000 | ||
| 2023-10-06 | SHAH BIMAL R. Director | Grant or award · Stock Option (right to buy) | +26,097 | 26,097 | ||
| 2022-12-09 | Cundy Kenneth C Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +35,017 | 35,017 |
Page 2 of 3 · 59 trades